Llwytho...
Docetaxel-Carboxymethylcellulose Nanoparticles Display Enhanced Anti-tumor Activity in Murine Models of Castration-Resistant Prostate Cancer
Docetaxel (DTX) remains the only effective drug for prolonging survival and improving quality of life of metastatic castration resistant prostate cancer (mCRPC) patients. Despite some clinical successes with DTX-based therapies, advent of cumulative toxicity and development of drug resistance limit...
Wedi'i Gadw mewn:
Prif Awduron: | , , , , |
---|---|
Fformat: | Artigo |
Iaith: | Inglês |
Cyhoeddwyd: |
2014
|
Pynciau: | |
Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4074574/ https://ncbi.nlm.nih.gov/pubmed/24853460 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ijpharm.2014.05.021 |
Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|